Evolus Inc (EOLS.OQ)

EOLS.OQ on NASDAQ Stock Exchange Global Market

1:30am IST
Change (% chg)

$-0.59 (-3.79%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address... (more)


Beta: --
Market Cap(Mil.): $495.18
Shares Outstanding(Mil.): 27.37
Dividend: --
Yield (%): --


UPDATE 1-Evolus reports sales of its Botox rival ahead of expectations

Aug 12 Medical aesthetics company Evolus Inc on Monday beat Wall Street estimates for second-quarter revenue from its newly launched rival to Allergan Plc's Botox, which has dominated the medical aesthetics market for more than a decade.

12 Aug 2019

Evolus says launch of its Botox rival ahead of its expectations

Aug 12 Evolus Inc on Monday reported revenue of $2.3 million from early sales of its newly launched rival to Allergan Plc's Botox, ahead of its own expectations.

12 Aug 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates